JR
Johannes Reynisson
Principal Investigator
Keele University
I'm working on
8 months ago
Drug discovery, biopharmaceutics, intracellular trafficking
About
Focuses on small‑molecule modulators of cancer pathways, connecting intracellular trafficking and autophagy with biopharmaceutics. Combines virtual/fragment screening and synthesis to deliver enzyme and chaperone inhibitors, validated by mechanism and pharmacology in cells and explants.
JR
Johannes Reynisson
Principal Investigator
Keele University
Work experience
Principal Investigator
Top industry applications
Oncology & cancer therapeuticsPharmaceuticals and drug delivery
Open to opportunities in
BiopharmaceuticsIntracellular Trafficking
Last updated Jan 2026
Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.